NASDAQ:ESTA Establishment Labs (ESTA) Stock Price, News & Analysis $48.20 +0.06 (+0.12%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$48.15▼$50.3050-Day Range$41.46▼$54.3752-Week Range$16.96▼$73.00Volume163,548 shsAverage Volume373,622 shsMarket Capitalization$1.33 billionP/E RatioN/ADividend YieldN/APrice Target$54.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Establishment Labs alerts: Email Address Establishment Labs MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.80 Rating ScoreUpside/Downside12.0% Upside$54.00 Price TargetShort InterestBearish20.76% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.13Based on 14 Articles This WeekInsider TradingSelling Shares$647,806 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.79) to ($0.72) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.01 out of 5 starsMedical Sector896th out of 936 stocksSurgical Appliances & Supplies Industry18th out of 18 stocks 2.4 Analyst's Opinion Consensus RatingEstablishment Labs has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageEstablishment Labs has only been the subject of 2 research reports in the past 90 days.Read more about Establishment Labs' stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted20.76% of the float of Establishment Labs has been sold short.Short Interest Ratio / Days to CoverEstablishment Labs has a short interest ratio ("days to cover") of 15.4, which indicates bearish sentiment.Change versus previous monthShort interest in Establishment Labs has recently decreased by 1.04%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldEstablishment Labs does not currently pay a dividend.Dividend GrowthEstablishment Labs does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ESTA. Previous Next 1.7 News and Social Media Coverage News SentimentEstablishment Labs has a news sentiment score of 0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 14 news articles for Establishment Labs this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for ESTA on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Establishment Labs insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $647,806.00 in company stock.Percentage Held by Insiders11.44% of the stock of Establishment Labs is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions72.91% of the stock of Establishment Labs is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Establishment Labs' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Establishment Labs are expected to grow in the coming year, from ($1.79) to ($0.72) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Establishment Labs is -15.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Establishment Labs is -15.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEstablishment Labs has a P/B Ratio of 67.89. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Establishment Labs' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyNvidia insiders dumping sharesAll the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.To see Porter Stansberry's new AI prediction go here now. About Establishment Labs Stock (NASDAQ:ESTA)Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.Read More ESTA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ESTA Stock News HeadlinesJuly 12, 2024 | insidertrades.comInsider Selling: Establishment Labs Holdings Inc. (NASDAQ:ESTA) CEO Sells 3,641 Shares of StockJuly 11, 2024 | insidertrades.comEstablishment Labs Holdings Inc. (NASDAQ:ESTA) CEO Quiros Juan Jose Chacon Sells 3,866 SharesJuly 27, 2024 | Porter & Company (Ad)Kiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but they do not care.July 4, 2024 | insidertrades.comEstablishment Labs Holdings Inc. (NASDAQ:ESTA) CEO Quiros Juan Jose Chacon Sells 6,839 SharesJuly 26 at 2:47 PM | news.yahoo.comVa. education board adopts new school accreditation regulationsJuly 26 at 2:47 PM | msn.comIndia to set up data innovation lab to address data-related challenges, guidelines notifiedJuly 24 at 11:38 AM | finance.yahoo.comEstablishment Labs to Announce Second Quarter 2024 Financial Results on August 6July 24 at 1:29 AM | finance.yahoo.comInvestors bid Establishment Labs Holdings (NASDAQ:ESTA) up US$50m despite increasing losses YoY, taking five-year CAGR to 13%July 27, 2024 | Porter & Company (Ad)Kiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but they do not care.July 22, 2024 | msn.comFood hygiene ratings given to 21 Thanet establishmentsJuly 20, 2024 | msn.comGrapevine July 21, 2024: More than a yellow ribbonJuly 20, 2024 | msn.comHow did Harley die? N.J. family awaits answers after dog’s groomer is arrested on drug charges.July 20, 2024 | msn.comIt’s time to be blunt: too many young people have worthless degreesJuly 20, 2024 | nypost.comWhy science should never try to triumph over natureJuly 20, 2024 | markets.businessinsider.comBuy Rating Affirmed for ESTA Amid Market Recovery and Anticipated FDA ApprovalJuly 20, 2024 | msn.comSavoring Philly: Exploring Philadelphia's Food SceneJuly 20, 2024 | msn.comIs heat wave helping spread of bird flu?July 18, 2024 | americanbankingnews.comEstablishment Labs (NASDAQ:ESTA) Shares Up 5.4%See More Headlines Receive ESTA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Establishment Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/08/2024Today7/26/2024Next Earnings (Confirmed)8/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNASDAQ:ESTA CUSIPN/A CIK1688757 Webwww.establishmentlabs.com Phone(062) 434-2400FaxN/AEmployees960Year FoundedN/APrice Target and Rating Average Stock Price Target$54.00 High Stock Price Target$70.00 Low Stock Price Target$47.00 Potential Upside/Downside+12.0%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($3.14) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-78,500,000.00 Net Margins-53.12% Pretax Margin-53.43% Return on Equity-206.05% Return on Assets-29.39% Debt Debt-to-Equity Ratio3.38 Current Ratio4.24 Quick Ratio2.73 Sales & Book Value Annual Sales$165.15 million Price / Sales8.03 Cash FlowN/A Price / Cash FlowN/A Book Value$0.71 per share Price / Book67.89Miscellaneous Outstanding Shares27,510,000Free Float24,367,000Market Cap$1.33 billion OptionableOptionable Beta1.24 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Juan Jose Chacon Quiros (Age 52)Founder, CEO & Executive Director Comp: $913.37kMr. Rajbir Singh Denhoy (Age 54)Chief Financial Officer Comp: $570.29kMr. S. Ross Mansbach (Age 57)General Counsel & Chief Compliance Officer Comp: $379.53kMr. Roberto de Mezerville (Age 43)Chief Technology Officer Mr. Salvador Santos Dada (Age 42)Head of Special Projects Comp: $468.62kMs. Rosalyn Cole d'IncelliSVP of Global Clinical, Medical & US Regulatory AffairsMs. Elizabeth Panzica NewmanVP & Head of U.S Business UnitMr. Ivan BilicSenior Vice President of Commercial Operations - OUSMs. Neeta TopraniCorporate SecretaryMore ExecutivesKey CompetitorsEargoNASDAQ:EARInogenNASDAQ:INGNInvacareNYSE:IVCPROCEPT BioRoboticsNASDAQ:PRCTInari MedicalNASDAQ:NARIView All CompetitorsInsiders & InstitutionsBay Colony Advisory Group Inc d b a Bay Colony AdvisorsBought 8,199 shares on 7/24/2024Ownership: 0.030%Stableford Capital II LLCBought 11,287 shares on 7/23/2024Ownership: 0.153%SG Americas Securities LLCBought 6,658 shares on 7/12/2024Ownership: 0.024%Quiros Juan Jose ChaconSold 3,641 sharesTotal: $163,990.64 ($45.04/share)CWM LLCSold 22,107 shares on 7/10/2024Ownership: 0.338%View All Insider TransactionsView All Institutional Transactions ESTA Stock Analysis - Frequently Asked Questions How have ESTA shares performed this year? Establishment Labs' stock was trading at $25.89 at the start of the year. Since then, ESTA shares have increased by 86.2% and is now trading at $48.20. View the best growth stocks for 2024 here. How were Establishment Labs' earnings last quarter? Establishment Labs Holdings Inc. (NASDAQ:ESTA) posted its quarterly earnings results on Wednesday, May, 8th. The company reported ($0.58) EPS for the quarter, topping the consensus estimate of ($0.65) by $0.07. The business's revenue for the quarter was down 20.1% on a year-over-year basis. When did Establishment Labs IPO? Establishment Labs (ESTA) raised $50 million in an initial public offering (IPO) on Thursday, July 19th 2018. The company issued 3,100,000 shares at a price of $15.00-$17.00 per share. Jefferies and Cowen acted as the underwriters for the IPO and BTIG was co-manager. Who are Establishment Labs' major shareholders? Top institutional shareholders of Establishment Labs include CWM LLC (0.34%), Stableford Capital II LLC (0.15%), Bay Colony Advisory Group Inc d b a Bay Colony Advisors (0.03%) and SG Americas Securities LLC (0.02%). Insiders that own company stock include Jw Asset Management, Llc, Nicholas Sheridan Lewin, Quiros Juan Jose Chacon, Lisa Gersh, Dennis E Condon, Raj Denhoy, Leslie Gillin and Edward J Schutter. View institutional ownership trends. How do I buy shares of Establishment Labs? Shares of ESTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Establishment Labs own? Based on aggregate information from My MarketBeat watchlists, some other companies that Establishment Labs investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Sientra (SIEN), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM) and This page (NASDAQ:ESTA) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Establishment Labs Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Establishment Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
